69818-3

2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --5 days post dose ifosfamide

Active

Part Description

LP65317-7 2-Dechloroethylifosfamide
2-Dechlroethylifosfamide (2-DCE-IF) is a metabolite that results from dealkylation of ifosfamide (IF), a chemotherapeutic agent used to treat solid tumors. The production of the 2-DCE-IF metabolites leads to equimolar amounts of chloroacetaldehyde, which is thought to be responsible for the nephrotoxic and neurotoxic adverse-effects associated with IF. Therefore, elevated levels of 2-DCE-IF lead to an increase risk for nephrotoxicity. PMID: 18825700 Source: Regenstrief LOINC, PMID: 18825700

LOINC Names Get Info

Fully-Specified Name: 2-Dechloroethylifosfamide^5D post dose ifosfamide:MCnc:24H:Urine:Qn:
Long Common Name: 2-Dechloroethylifosfamide [Mass/volume] in 24 hour Urine --5 days post dose ifosfamide
Short Name: 2-DCE-IF 5D p IFF 24h Ur-mCnc
Display Name: 2-Dechloroethylifosfamide 5 days post dose ifosfamide (24H U) [Mass/Vol]
Consumer Name Alpha Get Info: 2-Dechloroethylifosfamide 5 days after Ifosfamide, Urine

Part Model Get Info

Component
2-Dechloroethylifosfamide^5D post dose ifosfamide
LP307800-5
- Analyte
  2-Dechloroethylifosfamide
  LP65317-7
  - Component Numerator
    2-Dechloroethylifosfamide
    LP65317-7
    - Component Numerator Core
      2-Dechloroethylifosfamide
      LP65317-7
    - Component Numerator Core Suffix
      NULL
  - Component Denominator
    NULL
    - Component Denominator Core
      NULL
    - Component Denominator Core Suffix
      NULL
- Challenge
  5D post dose ifosfamide
  LP65325-0
- Adjustment
  NULL
- Count
  NULL
Property
MCnc
LP6827-2
Time
24H
LP6924-7
- Time Core
  24H
  LP6924-7
- Time Modifier
  NULL
System
Urine
LP7681-2
- System Core
  Urine
  LP7681-2
- Super System
  NULL
Scale
Qn
LP7753-9
Method
NULL

Basic Attributes

Class: DRUG/TOX
Type: Laboratory
First Released: Version 2.40
Last Updated: Version 2.70 (MIN)
Order vs. Observation: Both

Language Variants Get Info

Tag	Language	Translation
cs-CZ	Czech (Czechia)	2-dechlorethylifosfamid^5dní po podání dávky ifosfamidu:Hmotnostní koncentrace:24 hodin:Moč:Kvantitativní:
el-GR	Greek (Greece)	2-Δεχλωροαιθυλιφοσφαμίδη^5 ημέρες κατόπιν δόσης ιφοσφαμίδης:MCnc:24H:Ούρα:Qn: Synonyms: 24H 2-Δεχλωροαιθυλιφοσφαμίδη 5 ημέρες κατόπιν δόσης ιφοσφαμίδης DRUG/TOX MCnc Qn κατόπιν δόσης κατόπιν δόσης ιφοσφαμίδης Ούρα
es-ES	Spanish (Spain)	2-Decloroetilifosfamida^5D pos dosis de ifosfamida:Concentración de masa:24 horas:Orina:Qn: Synonyms: Cuantitativo
es-MX	Spanish (Mexico)	2-decloroetilifosfamida^5D después de la dosis de ifosfamida:Concentración de masa:24H:Orina:Cuantitativo:
fr-CA	French (Canada)	2-dechloroéthylifosfamide^5 j post dose ifosfamide:Concentration de masse:24 h:Urine:Quantitatif:
fr-FR	French (France)	2-déchloroéthylifosfamide^TJ05 après ifosfamide:Masse/Volume:24H:Urine:Numérique:
fr-BE	French (Belgium)	2-Dechloroéthylifosfamide^post dose ifosfamide. 5j:Concentration de masse:24 h:Urine:Quantitatif:
it-IT	Italian (Italy)	2-Decloroetilifosfamide^5 gg post dose ifosfamide,5 giorni dopo dose di ifosfamide,5die post dose if:MCnc:24h:Urine:Qn: Synonyms: 24 Ore Concentrazione di Massa dopo dose dopo dose di ifosfamide Livelli farmacologici e tossicologia
nl-NL	Dutch (Netherlands)	2-dechloorethylifosfamide^5 dagen na dosis ifosfamide:massa/volume:24 uur:urine:kwantitatief: Synonyms: 24U 5D na dosis ifosfamide
pl-PL	Polish (Poland)	2-Dechloroetylofosfamid^5D po dawce ifosfamidu:stężenie masowe:24h:mocz:ilościowy: Synonyms: 24 godziny 5 dni po podaniu dawki ifosfamidu po podaniu dawki po podaniu dawki ifosfamidu
ru-RU	Russian (Russian Federation)	2-Дехлорэтилифосфамид^5 дней после дозы ифосфамида:МассКонц:24 часа:Моча:Колич: Synonyms: Количественный Массовая концентрация
tr-TR	Turkish (Turkey)	2-Dekloroetilifosfamide^5G snr ifosfamid dozu:KütlKons:24Sa:İdrar:Kant:
zh-CN	Chinese (China)	2-脱氯乙基异环磷酰胺^在给予剂量异环磷酰胺之后5天:质量浓度:24小时:尿液:定量型: Synonyms: 120Hr之后于给予一剂异环磷酰胺;120Hr之后于给予剂量异环磷酰胺;120小时之后于给予一剂异环磷酰胺;120小时之后于给予剂量异环磷酰胺;5D之后于给予一剂异环磷酰胺;5D之后于给予剂量异环磷酰胺;5天之后于给予一剂异环磷酰胺;5天之后于给予剂量异环磷酰胺;在给予一剂异环磷酰胺之后120Hr;在给予一剂异环磷酰胺之后120小时;在给予一剂异环磷酰胺之后5D;在给予一剂异环磷酰胺之后5天;在给予剂量异环磷酰胺之后120Hr;在给予剂量异环磷酰胺之后120小时;在给予剂量异环磷酰胺之后5D 1天;1日;24.0小时;一天;一日;二十四个小时;二十四小时 2d-Ifo;2D-ifosfamide;2D-异环磷酰胺;2-脱氯乙基-异环磷酰胺;异环磷酰胺代谢产物 Ⅱ Holoxan Ifex IFF IFO Ifosfamide II Mitoxana XXX刺激 - 在...之后一剂物质一剂药物之后于... 之后于剂量物质;之后于剂量药物;在剂量物质之后之后于给予一剂异环磷酰胺;之后于给予剂量异环磷酰胺;在给予一剂异环磷酰胺之后全菲那剂量物质匹服平可用数量表示的;定量性;数值型;数量型;连续数值型标尺和乐生在...以后在后宜佛斯酰胺宜佛期酰胺尿;小便;下泉异磷酰胺毒品毒品类水平;浓度;质量浓度(单位体积) 药品类药物药物/毒理学;药物/毒理学试验;药物毒理学试验;药物毒理学试验类药物类

Example Units

Unit	Source
mg/L	Example UCUM Units

LOINC Terminology Service (API) using HL7^® FHIR^® Get Info

CodeSystem lookup: https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=69818-3

LOINC Copyright

Copyright © Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://loinc.org/license for the full LOINC copyright and license.